8-K: Corvus Pharmaceuticals Holds 2024 Annual Meeting, Elects Director and Ratifies Accounting Firm
Annual Meeting Results
Corvus Pharmaceuticals held its 2024 Annual Meeting of Stockholders, where a director was elected, the accounting firm was ratified, and executive compensation was approved on an advisory basis.
Summary
- Corvus Pharmaceuticals held its 2024 Annual Meeting of Stockholders on June 13, 2024.
- Stockholders of record as of April 18, 2024, were eligible to vote.
- There were 49,038,582 shares of common stock outstanding and entitled to vote.
- A total of 35,968,782 shares were voted in person or by proxy.
- Scott W. Morrison was elected as a Class II director to hold office until the 2027 Annual Meeting.
- PricewaterhouseCoopers LLC was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- The compensation of the company's named executive officers was approved on a non-binding advisory basis.
Sentiment
Score: 7
Explanation: The document reflects standard corporate governance procedures and shareholder approvals, indicating a neutral to slightly positive sentiment.
Positives
- The election of the director and ratification of the accounting firm passed with strong support from shareholders.
- The advisory vote on executive compensation was also approved, indicating general shareholder satisfaction.
Industry Context
This is a standard annual meeting report, typical for publicly traded companies, focusing on corporate governance matters.
Comparison to Industry Standards
- The voting results are typical for annual meetings, with most proposals passing with a majority of votes.
- The election of directors and ratification of auditors are standard procedures for publicly listed companies like Corvus Pharmaceuticals.
- The advisory vote on executive compensation is a common practice, allowing shareholders to express their views on pay packages.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Class II Director | Scott W. Morrison | 2024-06-13 | Elected at the Annual Meeting |
Stakeholder Impact
- Shareholders have exercised their voting rights on key corporate matters.
- The election of a director and ratification of the accounting firm provide assurance of corporate governance.
Key Dates
| Date | Description |
|---|---|
| 2024-04-18 | Record date for the Annual Meeting of Stockholders. |
| 2024-04-26 | Date the Definitive Proxy Statement was filed with the SEC. |
| 2024-06-13 | Date of the 2024 Annual Meeting of Stockholders. |
| 2024-06-14 | Date of the 8-K filing. |
Keywords
Annual Meeting, Stockholders, Director Election, Accounting Firm, Executive Compensation, Corporate Governance, Shareholder Vote
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.